Insights On Solid Dose Manufacturing

  1. Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems 4/20/2026

    Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

  2. Integration From Formulation Development To Manufacturing, Packaging 2/27/2025

    Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

  3. Rational Design And Material-sparing Strategies For Enabled Intermediates And Drug Products 9/9/2026

    A material-sparing strategy integrating formulation mapping, lab-scale spray drying, and compact screening can accelerate risk identification and inform first-round tablet formulation decisions for poorly soluble APIs.

  4. Breaking The GLP-1 Manufacturing Bottleneck: Single Use For Safer Scale Up 9/23/2026

    Streamline GLP-1 scale-up by replacing heavy container cleaning with single-use powder handling to boost containment and manufacturing capacity.

  5. Reducing Uncertainty In Early Oral Drug Development 8/31/2026

    Five recurring decision points in early oral solid dose development carry outsized downstream consequences. AI/ML-driven predictive modeling is reframing how teams manage those decisions under API and timeline constraints.

  6. HPAPI Containment: A Full Lifecycle Safety Innovation 6/15/2026

    Containing highly potent APIs across a full operational lifecycle requires a structured approach that addresses hazard scoring, quality by design, performance testing, and safe enclosure disposal.

  7. GLP-1 Oral Solid Dosage Workflow - Spray Drying And Tableting 6/29/2026

    Optimize containment in oral GLP-1 solid dose manufacturing. Learn how closed single-use containment and flexible isolators secure blending, spray drying, and tableting workflows.

  8. Oral Delivery Of PROTACs: Integrating Molecular Design And Enabling Formulation 8/20/2026

    Explore how integrated molecular design and formulation strategies can overcome the unique oral-delivery challenges of PROTACs, transforming complex degraders into viable, scalable medicines.

  9. Modern Containment Solutions In OSD Processes 6/15/2026

    Outdated containment infrastructure in OSD facilities creates costly compliance gaps and operational bottlenecks. Flexible single-use isolator systems offer a faster, more adaptable path forward.

  10. Navigating High-Potency OSD Manufacturing 4/13/2026

    Learn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.